The Influence of Personalised Sarcoma Care (PERSARC) Prediction Modelling on Clinical Decision Making in a Multidisciplinary Setting

Table 4

Chosen treatment options with and without the use of PERSARC.

	Without PERSARC, N (%)	With PERSARC, N (%)
Neoadjuvant radiotherapy
Surgery R0	10 (27.7%)	25 (69.4%)
Surgery R1	13 (36.1%)	6 (16.7%)
Surgery R2	2 (5.6%)	0 (0.0%)
Surgery
Amputation	5 (13.8%)	1 (2.8%)
R0	2 (5.6%)	1 (2.8%)
R1	1 (2.8%)	3 (8.3%)
R2	2 (5.6%)	0 (0.0%)
Adjuvant radiotherapy
Surgery R0	0 (0.0%)	0 (0.0%)
Surgery R1	1 (2.8%)	0 (0.0%)
Surgery R2	0 (0.0%)	0 (0.0%)